Cargando…
p53 accumulation is a strong predictor of recurrence in estrogen receptor-positive breast cancer patients treated with aromatase inhibitors
Aromatase inhibitors have played a central role in endocrine therapy for estrogen receptor (ER)-positive breast cancer in postmenopausal women. However, factors predictive of the efficacy of aromatase inhibitors, and prognostic factors, both for early and late recurrence in women treated with adjuva...
Autores principales: | Yamamoto, Mitsugu, Hosoda, Mitsuchika, Nakano, Kiichiroh, Jia, Shusheng, Hatanaka, Kanako C, Takakuwa, Emi, Hatanaka, Yutaka, Matsuno, Yoshihiro, Yamashita, Hiroko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317887/ https://www.ncbi.nlm.nih.gov/pubmed/24118529 http://dx.doi.org/10.1111/cas.12302 |
Ejemplares similares
-
PIK3CA mutation, reduced AKT serine 473 phosphorylation, and increased ERα serine 167 phosphorylation are positive prognostic indicators in postmenopausal estrogen receptor-positive early breast cancer
por: Ishida, Naoko, et al.
Publicado: (2018) -
Genetic heterogeneity during breast cancer progression in young patients
por: Hagio, Kanako, et al.
Publicado: (2021) -
Desmoplastic small round cell tumor of the parotid gland-report of a rare case and a review of the literature
por: Hatanaka, Kanako C., et al.
Publicado: (2019) -
High level expression of AMAP1 protein correlates with poor prognosis and survival after surgery of head and neck squamous cell carcinoma patients
por: Sato, Hiroki, et al.
Publicado: (2014) -
The prognosis of endometrial cancers stratified with conventional risk factors and modified molecular classification
por: Yamazaki, Hiroyuki, et al.
Publicado: (2022)